0000000000588888

AUTHOR

Francesca Timoneri

showing 20 related works from this author

CD40 activation in human pancreatic islets and ductal cells.

2008

Aims/hypothesis: CD40 expression on non-haematopoietic cells is linked to inflammation. We previously reported that CD40 is expressed on isolated human and non-human primate islets and its activation results in secretion of IL-8, macrophage inflammatory protein 1-beta (MIP-1β) and monocyte chemoattractant protein-1 (MCP-1) through nuclear factor-κB and extracellularly regulated kinases 1/2 pathways. The objective of this study was to identify the pattern of gene expression, and to study viability and functionality affected by CD40-CD40 ligand (CD40L) interaction in human islets. Furthermore, we have studied the CD40-mediated cytokine/chemokine profile in pancreatic ductal cells, as they are…

AdultChemokinemedicine.medical_specialtyDuctal cellsCell SurvivalEndocrinology Diabetes and Metabolismmedicine.medical_treatmentChemokine CXCL1CD40 Chemokines Cytokines Ductal cells Inflammation Insulin Islets of Langerhans Microarray Quantitative RT-PCRCD40 LigandEnzyme-Linked Immunosorbent AssayIslets of LangerhansYoung AdultInternal medicineInternal MedicinemedicineHumansCD40 AntigensMacrophage inflammatory proteinOligonucleotide Array Sequence AnalysisCD40biologySettore BIO/16 - Anatomia UmanaReverse Transcriptase Polymerase Chain ReactionPancreatic isletsPancreatic DuctsMiddle AgedFlow CytometryMolecular biologyCXCL1CXCL2Endocrinologymedicine.anatomical_structureCytokinebiology.proteinCytokinesChemokinesDiabetologia
researchProduct

Wharton’s Jelly Mesenchymal Stromal Cells from Human Umbilical Cord: a Close-up on Immunomodulatory Molecules Featured In Situ and In Vitro

2019

Therapeutic options for end-stage organ failure are often limited to whole organ transplantation. The tolerance or rejection of the transplanted organ is driven by both early non-specific innate and specific adaptive responses. The use of mesenchymal stromal cells (MSCs) is considered a promising tool in regenerative medicine. Human umbilical cord (HUC) is an easily available source of MSCs, without relevant ethical issues. Moreover, Wharton's jelly-derived MSCs (WJ-MSCs), showed consistent immunomodulatory features that may be useful to promote immune tolerance in the host after transplantation. Few data are available on the phenotype of WJ-MSCs in situ. We investigated the expression of i…

0301 basic medicineSettore BIO/17 - IstologiaB7 AntigensT cellIn Vitro TechniquesBiologyLymphocyte ActivationRegenerative medicineCell therapyUmbilical CordImmune toleranceImmunomodulation03 medical and health sciences0302 clinical medicineWharton's jellymedicineHumansWharton JellyCD276Cells CulturedCell ProliferationStem cellMesenchymal stem cellCell DifferentiationMesenchymal Stem CellsHuman umbilical cordCell biologyTransplantationTolerance induction030104 developmental biologymedicine.anatomical_structureB7-H3030220 oncology & carcinogenesisLymphocyte inhibitionRegenerative medicineCytokinesWharton’s jelly mesenchymal stromal cellsStem cell
researchProduct

Prolactin supplementation to culture medium improves beta-cell survival

2010

OBJECTIVES.: Recent studies demonstrated that prolactin (PRL) has beneficial effects on β cells for islet transplantation. We examined the effect of human recombinant PRL (rhPRL) supplementation to the culture media to determine its potential use in the context of clinical islet transplantation. MATERIALS AND METHODS.: Each human islet isolated from 14 deceased multiorgan donors was cultured in Miami modified media-1 supplemented with or without rhPRL (500 μg/L) for 48 hr. β-Cell survival and proliferation (BrdU and Ki-67) were determined by laser scanning cytometry. The cytoprotective effects of rhPRL against noxious stimuli were assessed by flow cytometry (tetramethylrhodamine ethyl ester…

endocrine systemmedicine.medical_specialtyAdenosineCell SurvivalAllopurinolmedicine.medical_treatmentOrgan Preservation SolutionsTransplantation HeterologousCell Culture TechniquesIslets of Langerhans TransplantationApoptosisContext (language use)BiologyArticleMiceRaffinoseInsulin-Secreting CellsInternal medicineCadavermedicineAnimalsHumansInsulinTransplantationgeographygeography.geographical_feature_categorySettore BIO/16 - Anatomia UmanaInsulinIsletGlutathioneRecombinant ProteinsTissue DonorsProlactinCulture MediaProlactinProlactin Pancreatic Islets InflammationTransplantationEndocrinologyCytokineApoptosisCell cultureCytokinesChemokinesCell Divisionhormones hormone substitutes and hormone antagonists
researchProduct

Isolation and phenotypical characterization of mesenchymal stem cells from the Wharton's jelly of pre-term human umbilical cord.

2014

Settore BIO/16 - Anatomia Umanamesenchymal stem cells pre-term human umbilical cord Wharton's jelly
researchProduct

ISOLATION AND PHENOTYPICAL CHARACTERIZATION OF MESENCHYMAL STEM CELLS FROM PRE-TERM HUMAN UMBILICAL CORD MATRIX

2012

MESENCHYMAL STEM CELLS PRE-TERM HUMAN UMBILICAL CORD MATRIXSettore BIO/16 - Anatomia Umana
researchProduct

Hepatocyte-like cells differentiated from Wharton's jelly mesenchymal stem cells: functional characterization and expression of immunomodulatory mole…

2014

Settore BIO/16 - Anatomia UmanaMesenchymal cells hepatocyte WJ-MSC immonumodulatory activity.
researchProduct

Characterization of the in vitro immunomodulatory properties of mesenchymal stem cells isolated from Wharton's jelly: new actors at play

2014

Settore BIO/16 - Anatomia Umanamesenchymal stem cells wharton's jelly umbilical cord WJ-MSC
researchProduct

Wharton's jelly mesencymal stem cells differentiated into hepatocyte-like cells show expression of immunomodulatory molecules

2014

Settore BIO/16 - Anatomia UmanaWharton's jelly mesenchymal stem cells umbilical cord cell therapy regenerative medicine immunomodulatory molecules
researchProduct

Isolation and phenotypical characterization of mesenchymal stem cells from the Wharton's jelly of pre-term human umbilical cord

2014

Settore BIO/16 - Anatomia UmanaUmbilical cord perinatal stem cells mesenchymal stem cells immune modulation isolation protocol cell culture markers
researchProduct

Wharton’s jelly mesenchymal stem cells differrentiation towards hepatocyte-like cells: in vitro evidences

2012

Settore BIO/16 - Anatomia UmanaWharton’s jelly mesenchymal stem cells differrentiationhepatocyte-like cells
researchProduct

Shifting back the fetomaternal interface: WHarton's jelly mesenchymal stem cells immunomodulatory molecules and their journey from umbilical cord to …

2014

Settore BIO/16 - Anatomia Umanawharton's jelly stem cells umbilical cord WJ-MSC
researchProduct

Wharton's jelly immunomodulatory properties and unique markers expression: new actors at play

2014

Settore BIO/16 - Anatomia UmanaUmbilical cord wharton's jelly MSC markers immunomodulatory.
researchProduct

Characterization of the immunomodulatory properties of mesenchymal stem cells isolated from Wharton's jelly

2012

Settore BIO/16 - Anatomia UmanaWharton's jelly umbilical cord mesenchymal stem cells immune modulation regenerative medicine differentiation
researchProduct

Wharton's jelly mesenchymal stem cells differentiation towards hepatocyte-like cells: functional characterization and expression of immunomodulatory …

2012

Wharton's jelly mesenchymal stem cells hepatocyte liver diseases immune modulation immune functionSettore BIO/16 - Anatomia Umana
researchProduct

Wharton's jelly mesenchymal stem cells differentiation towards hepatocyte-like cells: functional characterization and expression of immunomodulatory …

2014

Settore BIO/16 - Anatomia Umanahepatocyte-like HLA-E WJ-MSC wharton's jelly
researchProduct

Wharton’s Jelly Mesenchymal Stem Cells from Preterm Umbilical Cords: Isolation, Characterization and Potential Use as Extrahepatic Progenitors

2014

multipotent progenitor cellcell differentiationhepatogenic differentiationSettore BIO/16 - Anatomia Umanaumbilical cordwharton's jellyregenerative medicinephenotypic characteristicmesenchymal stem cell
researchProduct

Wharton’s jelly mesenchymal stem cells differentiation into hepatocyte-like cells: functional characterization and expression of immunomodulatory mol…

2015

Mesenchymal stem cells derived from Wharton’s jelly (WJ-MSCs) recently emerged as promising tools for cellular therapy due to their ability to differentiate into diverse cell types and their immunomodulatory features. Little is known on the expression of immunomodulatory molecules in mature cells differentiated from WJ-MSCs, therefore we aimed to characterize the extent of maintenance of the naive traits of these cells also in a highly specialized differentiated counterpart. WJ-MSCs were differentiated into hepatocyte-like cells (HLCs) with a four weeks protocol. RT-PCR, flow cytometry, IHC and ICC were performed to assess expression of key markers in both undifferentiated and differentiate…

hepatocyte differentiationmesenchymal stem cellsimmune modulationUmbilical cord; perinatal stem cells; mesenchymal stem cells; hepatocyte differentiation; immune modulation.Settore BIO/16 - Anatomia UmanaWharton's jellyperinatal stem cellcell therapyUmbilical cordliver
researchProduct

Immune-related molecole are espresse by both naive and differentiated Wharton’s jelly mesenchymal stem cells: a new avenue for cellular therapy

2012

Immune-related molecole Wharton’s jelly mesenchymal stem cells cellular therapy.Settore BIO/16 - Anatomia Umana
researchProduct

Wharton's jelly mesenchymal stem cells immunomodulatory molecules: their journey from umbilical cord to differentieted cells.

2014

Settore BIO/16 - Anatomia UmanaWJ-MSC IHC ICC HLA-ABC B7-H3 mesenchymal stem cells.
researchProduct

Younger is better? Isolation and phenotypical characterization of mesenchymal stem cells from the Wharton's jelly of pre-term human umbilical cords

2014

full term umbilical cords TUC PTUC pre-term umbilical cords WJ-MSC CD29 CD44 CD73 CD90 CD 105 MHC I B7-H3.Settore BIO/16 - Anatomia Umana
researchProduct